{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:16:23Z","timestamp":1771359383938,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-025-00171-7","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:17:13Z","timestamp":1767867433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing infection diagnostics in advanced chronic liver disease: harnessing clinical metagenomics for rapid pathogen and antimicrobial resistance detection"],"prefix":"10.1038","volume":"4","author":[{"given":"Merianne","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysi","family":"Sergaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"171_CR1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(13)62152-2","volume":"382","author":"R Williams","year":"2013","unstructured":"Williams, R. & Horton, R. Liver disease in the UK: a Lancet Commission. Lancet 382, 1537\u20131538 (2013).","journal-title":"Lancet"},{"key":"171_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","volume":"19","author":"A Albillos","year":"2022","unstructured":"Albillos, A. et al. Cirrhosis-associated immune dysfunction. Nat. Rev. Gastroenterol. Hepatol. 19, 112\u2013134 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"171_CR3","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2020.11.029","volume":"75","author":"S Van der Merwe","year":"2021","unstructured":"Van der Merwe, S. et al. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J. Hepatol. 75, S82\u2013S100 (2021).","journal-title":"J. Hepatol."},{"key":"171_CR4","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","volume":"62","author":"V Arroyo","year":"2015","unstructured":"Arroyo, V. et al. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J. Hepatol. 62, S131\u2013S143 (2015).","journal-title":"J. Hepatol."},{"key":"171_CR5","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer, R. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit. Care Med. 42, 1749\u20131755 (2014).","journal-title":"Crit. Care Med."},{"key":"171_CR6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","volume":"56","author":"YM Arabi","year":"2012","unstructured":"Arabi, Y. M. et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology 56, 2305\u20132315 (2012).","journal-title":"Hepatology"},{"key":"171_CR7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","volume":"70","author":"J Fernandez","year":"2019","unstructured":"Fernandez, J. et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J. Hepatol. 70, 398\u2013411 (2019).","journal-title":"J. Hepatol."},{"key":"171_CR8","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","volume":"156","author":"S Piano","year":"2019","unstructured":"Piano, S. et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 156, 1368\u20131380 e10 (2019).","journal-title":"Gastroenterology"},{"key":"171_CR9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan, R. et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J. Hepatol. 60, 1310\u20131324 (2014).","journal-title":"J. Hepatol."},{"key":"171_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/pgmj.2006.056168","volume":"83","author":"A Koulaouzidis","year":"2007","unstructured":"Koulaouzidis, A. et al. Spontaneous bacterial peritonitis. Postgrad. Med. J. 83, 379\u2013383 (2007).","journal-title":"Postgrad. Med. J."},{"key":"171_CR11","first-page":"142","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola, A. et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. Int. Ascites Club. J. Hepatol. 32, 142\u2013153 (2000).","journal-title":"Int. Ascites Club. J. Hepatol."},{"key":"171_CR12","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/jcm.27.10.2145-2147.1989","volume":"27","author":"M Bobadilla","year":"1989","unstructured":"Bobadilla, M., Sifuentes, J. & Garcia-Tsao, G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. J. Clin. Microbiol. 27, 2145\u20132147 (1989).","journal-title":"J. Clin. Microbiol."},{"key":"171_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581\u2013614 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"171_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S2468-1253(16)30240-0","volume":"2","author":"L Shallcross","year":"2017","unstructured":"Shallcross, L. & O\u2019Brien, A. Antimicrobial resistance in liver disease: better diagnostics are needed. Lancet Gastroenterol. Hepatol. 2, 151\u2013153 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"171_CR15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","volume":"4","author":"KJ Land","year":"2019","unstructured":"Land, K. J. et al. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat. Microbiol. 4, 46\u201354 (2019).","journal-title":"Nat. Microbiol."},{"key":"171_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fcimb.2020.00308","volume":"10","author":"A Vasala","year":"2020","unstructured":"Vasala, A., Hytonen, V. P. & Laitinen, O. H. Modern tools for rapid diagnostics of antimicrobial resistance. Front. Cell Infect. Microbiol. 10, 308 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"171_CR17","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-024-05224-3","volume":"28","author":"FJ Candel","year":"2024","unstructured":"Candel, F. J. et al. The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document. Crit. Care 28, 440 (2024).","journal-title":"Crit. Care"},{"key":"171_CR18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrmicro.2017.103","volume":"15","author":"CD Burnham","year":"2017","unstructured":"Burnham, C. D. et al. Diagnosing antimicrobial resistance. Nat. Rev. Microbiol 15, 697\u2013703 (2017).","journal-title":"Nat. Rev. Microbiol"},{"key":"171_CR19","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1016\/S2666-5247(23)00285-9","volume":"4","author":"NE Wheeler","year":"2023","unstructured":"Wheeler, N. E. et al. Innovations in genomic antimicrobial resistance surveillance. Lancet Microbe 4, e1063\u2013e1070 (2023).","journal-title":"Lancet Microbe"},{"key":"171_CR20","volume":"11","author":"HX Wu","year":"2023","unstructured":"Wu, H. X. et al. Clinical evaluation of metagenomic next-generation sequencing method for the diagnosis of suspected ascitic infection in patients with liver cirrhosis in a clinical laboratory. Microbiol Spectr. 11, e0294622 (2023).","journal-title":"Microbiol Spectr."},{"key":"171_CR21","doi-asserted-by":"crossref","unstructured":"Themoula Charalampous, G. L. K. & O\u2019Grady, Justin Applying clinical metagenomics for the detection and characterisation of respiratory infections. in Eur Respir Monogr, (2019).","DOI":"10.1183\/2312508X.10015618"},{"key":"171_CR22","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-024-01835-5","volume":"17","author":"L Moragues-Solanas","year":"2024","unstructured":"Moragues-Solanas, L. et al. Development and proof-of-concept demonstration of a clinical metagenomics method for the rapid detection of bloodstream infection. BMC Med Genomics 17, 71 (2024).","journal-title":"BMC Med Genomics"},{"key":"171_CR23","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02156-21","volume":"60","author":"TL Street","year":"2022","unstructured":"Street, T. L. et al. Clinical metagenomic sequencing for species identification and antimicrobial resistance prediction in orthopedic device infection. J. Clin. Microbiol. 60, e0215621 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"171_CR24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41564-022-01089-w","volume":"7","author":"KKK Ko","year":"2022","unstructured":"Ko, K. K. K., Chng, K. R. & Nagarajan, N. Metagenomics-enabled microbial surveillance. Nat. Microbiol 7, 486\u2013496 (2022).","journal-title":"Nat. Microbiol"},{"key":"171_CR25","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41396-019-0446-4","volume":"13","author":"T Stalder","year":"2019","unstructured":"Stalder, T. et al. Linking the resistome and plasmidome to the microbiome. ISME J. 13, 2437\u20132446 (2019).","journal-title":"ISME J."},{"key":"171_CR26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s43856-024-00696-4","volume":"4","author":"JK Valik","year":"2024","unstructured":"Valik, J. K. et al. Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection. Commun. Med. 4, 264 (2024).","journal-title":"Commun. Med."},{"key":"171_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-020-00993-9","volume":"9","author":"L de Nies","year":"2021","unstructured":"de Nies, L. et al. PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome 9, 49 (2021).","journal-title":"Microbiome"},{"key":"171_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu, C. Y. & Miller, S. A. Clinical metagenomics. Nat. Rev. Genet. 20, 341\u2013355 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"171_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-90777-8","volume":"15","author":"R Napit","year":"2025","unstructured":"Napit, R. et al. Metagenomic analysis of human, animal, and environmental samples identifies potential emerging pathogens, profiles antibiotic resistance genes, and reveals horizontal gene transfer dynamics. Sci. Rep. 15, 12156 (2025).","journal-title":"Sci. Rep."},{"key":"171_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-021-00991-y","volume":"13","author":"T Charalampous","year":"2021","unstructured":"Charalampous, T. et al. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units. Genome Med 13, 182 (2021).","journal-title":"Genome Med"},{"key":"171_CR31","doi-asserted-by":"crossref","first-page":"1191946","DOI":"10.3389\/fmicb.2023.1191946","volume":"14","author":"ME von Fricken","year":"2023","unstructured":"von Fricken, M. E. et al. Editorial: metagenomics for epidemiological surveillance in One Health. Front. Microbiol. 14, 1191946 (2023).","journal-title":"Front. Microbiol."},{"key":"171_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cjp2.151","volume":"6","author":"CA Selway","year":"2020","unstructured":"Selway, C. A., Eisenhofer, R. & Weyrich, L. S. Microbiome applications for pathology: challenges of low microbial biomass samples during diagnostic testing. J. Pathol. Clin. Res. 6, 97\u2013106 (2020).","journal-title":"J. Pathol. Clin. Res."},{"key":"171_CR33","doi-asserted-by":"crossref","unstructured":"Yang, C.J. et al. 16S rRNA next-generation sequencing may not be useful for examining suspected cases of spontaneous bacterial peritonitis. Medicina 60, (20240.","DOI":"10.3390\/medicina60020289"},{"key":"171_CR34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.amjmed.2021.01.015","volume":"134","author":"KA Campbell","year":"2021","unstructured":"Campbell, K. A., Trivedi, H. D. & Chopra, S. Infections in cirrhosis: a guide for the clinician. Am. J. Med 134, 727\u2013734 (2021).","journal-title":"Am. J. Med"},{"key":"171_CR35","volume":"23","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Early application of metagenomics next-generation sequencing may significantly reduce unnecessary consumption of antibiotics in patients with fever of unknown origin. BMC Infect. Dis. 23, 478 (2023).","journal-title":"BMC Infect. Dis."},{"key":"171_CR36","doi-asserted-by":"crossref","first-page":"1517208","DOI":"10.3389\/fcimb.2025.1517208","volume":"15","author":"I Butler","year":"2025","unstructured":"Butler, I. et al. Standardization of 16S rRNA gene sequencing using nanopore long read sequencing technology for clinical diagnosis of culture negative infections. Front Cell Infect. Microbiol 15, 1517208 (2025).","journal-title":"Front Cell Infect. Microbiol"},{"key":"171_CR37","unstructured":"AWHO collaborative study to evaluate the candidate WHO International Reference Reagent for DNA extraction of the Gut Microbiome. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-bs-2023.2455 (2023)."},{"key":"171_CR38","unstructured":"A WHO collaborative study to evaluate the candidate 1st WHO International Reference Reagents for Gut Microbiome analysis by Next-Generation Sequencing. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-bs-2022.2416 (2023)."},{"key":"171_CR39","doi-asserted-by":"crossref","unstructured":"Feldgarden, M. et al. Validating the AMRFinder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother. 63, (2019).","DOI":"10.1128\/AAC.00483-19"},{"key":"171_CR40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jgar.2021.03.016","volume":"25","author":"I Frost","year":"2021","unstructured":"Frost, I. et al. Status, challenges and gaps in antimicrobial resistance surveillance around the world. J. Glob. Antimicrob. Resist. 25, 222\u2013226 (2021).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"171_CR41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44259-024-00033-8","volume":"2","author":"J Hassall","year":"2024","unstructured":"Hassall, J. et al. Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects. NPJ Antimicrob. Resist. 2, 16 (2024).","journal-title":"NPJ Antimicrob. Resist."},{"key":"171_CR42","volume":"59","author":"KN Govender","year":"2021","unstructured":"Govender, K. N. et al. Metagenomic sequencing as a pathogen-agnostic clinical diagnostic tool for infectious diseases: a systematic review and meta-analysis of diagnostic test accuracy studies. J. Clin. Microbiol 59, e0291620 (2021).","journal-title":"J. Clin. Microbiol"},{"key":"171_CR43","doi-asserted-by":"crossref","unstructured":"Loit, K. et al. Relative Performance of MinION (Oxford Nanopore Technologies) versus Sequel (Pacific Biosciences) Third-Generation Sequencing Instruments in Identification of Agricultural and Forest Fungal Pathogens. Appl. Environ. Microbiol. 85 (2019).","DOI":"10.1128\/AEM.01368-19"},{"key":"171_CR44","volume":"23","author":"F Xu","year":"2025","unstructured":"Xu, F. et al. Impact of metagenomics next-generation sequencing on etiological diagnosis and early outcomes in sepsis. J. Transl. Med. 23, 394 (2025).","journal-title":"J. Transl. Med."},{"key":"171_CR45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-019-10004-1","volume":"14","author":"VC Patel","year":"2020","unstructured":"Patel, V. C. & Williams, R. Antimicrobial resistance in chronic liver disease. Hepatol. Int. 14, 24\u201334 (2020).","journal-title":"Hepatol. Int."},{"key":"171_CR46","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.jhep.2020.11.010","volume":"75","author":"J Fernandez","year":"2021","unstructured":"Fernandez, J. et al. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. J. Hepatol. 75, S101\u2013S117 (2021).","journal-title":"J. Hepatol."},{"key":"171_CR47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1164\/rccm.202305-0901OC","volume":"209","author":"T Charalampous","year":"2024","unstructured":"Charalampous, T. et al. Routine metagenomics service for ICU patients with respiratory infection. Am. J. Respir. Crit. Care Med. 209, 164\u2013174 (2024).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"171_CR48","doi-asserted-by":"crossref","first-page":"943859","DOI":"10.3389\/fcimb.2022.943859","volume":"12","author":"Q Deng","year":"2022","unstructured":"Deng, Q. et al. Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections. Front. Cell Infect. Microbiol. 12, 943859 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"171_CR49","doi-asserted-by":"crossref","first-page":"1473068","DOI":"10.3389\/fcimb.2024.1473068","volume":"14","author":"H Wu","year":"2024","unstructured":"Wu, H. et al. The role of metagenomic next-generation sequencing in diagnosing and managing post-kidney transplantation infections. Front. Cell Infect. Microbiol. 14, 1473068 (2024).","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00171-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:45:53Z","timestamp":1771357553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00171-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1038\/s44259-025-00171-7","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.C.P. declares consultancy roles with Resolution Therapeutics, Emles Bioventures, AlfaSigma S.p.A., AstraZeneca, Norgine Pharmaceuticals Ltd, and Menarini Diagnostics Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"VCP has delivered paid lectures for Norgine Pharmaceuticals Ltd, Alfasigma S.p.A. and Menarini Diagnostics Ltd. The views expressed in the publication are those of the author(s) and not necessarily those of the NHS, DHSC, \u2018arms\u2019 length bodies, DSIT or other government departments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}}],"article-number":"3"}}